{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:46:49Z","timestamp":1793375209314,"version":"4.5.0"},"reference-count":245,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiomyopathies are a heterogeneous group of heart muscle diseases and an important cause of heart failure (HF). Current knowledge on incidence, pathophysiology and natural history of HF in cardiomyopathies is limited, and distinct features of their therapeutic responses have not been systematically addressed. Therefore, this position paper focuses on epidemiology, pathophysiology, natural history and latest developments in treatment of HF in patients with dilated (DCM), hypertrophic (HCM) and restrictive (RCM) cardiomyopathies. In DCM, HF with reduced ejection fraction (HFrEF) has high incidence and prevalence and represents the most frequent cause of death, despite improvements in treatment. In addition, advanced HF in DCM is one of the leading indications for heart transplantation. In HCM, HF with preserved ejection (HFpEF) affects most patients with obstructive, and \u223c10% of patients with non-obstructive HCM. A timely treatment is important, since development of advanced HF, although rare in HCM, portends a poor prognosis. In RCM, HFpEF is common, while HFrEF occurs later and more frequently in amyloidosis or iron overload\/haemochromatosis. Irrespective of RCM aetiology, HF is a harbinger of a poor outcome. Recent advances in our understanding of the mechanisms underlying the development of HF in cardiomyopathies have significant implications for therapeutic decision-making. In addition, new aetiology-specific treatment options (e.g. enzyme replacement therapy, transthyretin stabilizers, immunoadsorption, immunotherapy, etc.) have shown a potential to improve outcomes. Still, causative therapies of many cardiomyopathies are lacking, highlighting the need for the development of effective strategies to prevent and treat HF in cardiomyopathies.<\/jats:p>","DOI":"10.1002\/ejhf.1461","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T03:24:07Z","timestamp":1555385047000},"page":"553-576","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":344,"title":["Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology"],"prefix":"10.1093","volume":"21","author":[{"given":"Petar M.","family":"Seferovi\u0107","sequence":"first","affiliation":[{"name":"University of Belgrade Faculty of Medicine , Belgrade ,","place":["Serbia"]},{"name":"Serbian Academy of Sciences and Arts , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Polovina","sequence":"additional","affiliation":[{"name":"University of Belgrade Faculty of Medicine , Belgrade ,","place":["Serbia"]},{"name":"Department of Cardiology, Clinical Center of Serbia , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Medical School Hannover , Hannover ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Arad","sequence":"additional","affiliation":[{"name":"Cardiomyopathy Clinic and Heart Failure Institute, Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuvia","family":"Ben Gal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Lund","sequence":"additional","affiliation":[{"name":"Department of Medicine, Karolinska Institutet, and Heart and Vascular Theme, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan B.","family":"Felix","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, University Medicine Greifswald , Greifswald ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Arbustini","sequence":"additional","affiliation":[{"name":"Centre for Inherited Cardiovascular Diseases, IRCCS Foundation, University Hospital Policlinico San Matteo , Pavia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida L.P.","family":"Caforio","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua , Padua ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Farmakis","sequence":"additional","affiliation":[{"name":"University of Cyprus Medical School, Nicosia, Cyprus; Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos S.","family":"Filippatos","sequence":"additional","affiliation":[{"name":"University of Cyprus Medical School, Nicosia, Cyprus; Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Gialafos","sequence":"additional","affiliation":[{"name":"Second Department of Cardiology, Heart Failure and Preventive Cardiology Section, Henry Dunant Hospital , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Kanjuh","sequence":"additional","affiliation":[{"name":"Serbian Academy of Sciences and Arts , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Krljanac","sequence":"additional","affiliation":[{"name":"University of Belgrade Faculty of Medicine , Belgrade ,","place":["Serbia"]},{"name":"Department of Cardiology, Clinical Center of Serbia , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Sciences, Universit\u00e0 della Campania \u2018Luigi VanvitellI\u2019, Monaldi Hospital, AORN Colli, Centro di Ricerca Cardiovascolare, Ospedale Monaldi, AORN Colli, Naples, Italy, and UCL Institute of Cardiovascular Science , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale\u0161","family":"Linhart","sequence":"additional","affiliation":[{"name":"Second Department of Medicine, Department of Cardiovascular Medicine, General University Hospital, Charles University in Prague , Prague ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Lyon","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru\u017eica","family":"Maksimovi\u0107","sequence":"additional","affiliation":[{"name":"University of Belgrade Faculty of Medicine , Belgrade ,","place":["Serbia"]},{"name":"Centre for Radiology and Magnetic Resonance Imaging, Clinical Centre of Serbia , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davor","family":"Mili\u010di\u0107","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, University Hospital Center Zagreb, University of Zagreb , Zagreb ,","place":["Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Milinkovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Clinical Center of Serbia , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Noutsias","sequence":"additional","affiliation":[{"name":"Mid-German Heart Center, Department of Internal Medicine III, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin-Luther-University Halle , Halle ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Oto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hacettepe University Faculty of Medicine , Ankara ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6ztekin","family":"Oto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Dokuz Eyl\u00fcl University Faculty of Medicine , \u0130zmir ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sini\u0161a U.","family":"Pavlovi\u0107","sequence":"additional","affiliation":[{"name":"University of Belgrade Faculty of Medicine , Belgrade ,","place":["Serbia"]},{"name":"Pacemaker Center, Clinical Center of Serbia , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo F.","family":"Piepoli","sequence":"additional","affiliation":[{"name":"Heart Failure Unit, Cardiology, G. da Saliceto Hospital , Piacenza ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsen D.","family":"Risti\u0107","sequence":"additional","affiliation":[{"name":"University of Belgrade Faculty of Medicine , Belgrade ,","place":["Serbia"]},{"name":"Department of Cardiology, Clinical Center of Serbia , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe M.C.","family":"Rosano","sequence":"additional","affiliation":[{"name":"Centre for Clinical and Basic Research, Department of Medical Sciences, IRCCS San Raffaele Pisana , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Seggewiss","sequence":"additional","affiliation":[{"name":"Medizinische Klinik, Kardiologie & Internistische Intensivmedizin, Klinikum W\u00fcrzburg-Mitte , W\u00fcrzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milika","family":"A\u0161anin","sequence":"additional","affiliation":[{"name":"University of Belgrade Faculty of Medicine , Belgrade ,","place":["Serbia"]},{"name":"Department of Cardiology, Clinical Center of Serbia , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena P.","family":"Seferovi\u0107","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]},{"name":"Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Center Serbia and Faculty of Medicine, University of Belgrade , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ruschitzka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center , Z\u00fcrich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"\u010celutkiene","sequence":"additional","affiliation":[{"name":"Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University , Vilnius ,","place":["Lithuania"]},{"name":"State Research Institute Centre for Innovative Medicine , Vilnius ,","place":["Lithuania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiny","family":"Jaarsma","sequence":"additional","affiliation":[{"name":"Department of Social and Welfare Studies, Faculty of Health Science, Link\u00f6ping University , Link\u00f6ping ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel , Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Moura","sequence":"additional","affiliation":[{"name":"Cardiology Department, Centro Hospitalar S\u00e3o Jo\u00e3o , Porto ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreena","family":"Hill","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery, Queen's University Belfast , Belfast ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Volterrani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, IRCCS San Raffaele Pisana , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Lopatin","sequence":"additional","affiliation":[{"name":"Volgograd State Medical University, Regional Cardiology Centre Volgograd , Volgograd ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Backs","sequence":"additional","affiliation":[{"name":"Department of Molecular Cardiology and Epigenetics, University of Heidelberg , Heidelberg ,","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research) partner site Heidelberg\/Mannheim , Heidelberg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Mullens","sequence":"additional","affiliation":[{"name":"BIOMED - Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University , Diepenbeek ,","place":["Belgium"]},{"name":"Department of Cardiology, Ziekenhuis Oost-Limburg , Genk ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Chioncel","sequence":"additional","affiliation":[{"name":"University of Medicine Carol Davila , Bucharest ,","place":["Romania"]},{"name":"Emergency Institute for Cardiovascular Diseases, \u2018Prof. C. C. Iliescu\u2019 , Bucharest ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Groningen, University of Groningen , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Anker","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charit\u00e9 , Berlin ,","place":["Germany"]},{"name":"Berlin-Brandenburg Center for Regenerative Therapies (BCRT) , Berlin ,","place":["Germany"]},{"name":"DZHK (German Centre for Cardiovascular Research) partner site Berlin, Charit\u00e9 , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Rapezzi","sequence":"additional","affiliation":[{"name":"Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum University of Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.S.","family":"Coats","sequence":"additional","affiliation":[{"name":"Monash University, Australia, and University of Warwick , Coventry ,","place":["UK"]},{"name":"Pharmacology, Centre of Clinical and Experimental Medicine, IRCCS San Raffaele Pisana, Rome, Italy, and St George's University of London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Tsch\u00f6pe","sequence":"additional","affiliation":[{"name":"Berlin-Brandenburg Center for Regenerative Therapies, Deutsches Zentrum f\u00fcr Herz-Kreislauf-Forschung (DZHK) Berlin, Department of Cardiology, Campus Virchow Klinikum, Charite - Universitaetsmedizin Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"key":"2026011721304240900_ejhf1461-bib-0001","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0002","first-page":"e38","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0003","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.CIR.80.3.564","article-title":"Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975\u20131984","volume":"80","author":"Codd","year":"1989","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0004","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/pgmj.54.633.435","article-title":"Incidence of congestive cardiomyopathy","volume":"54","author":"Torp","year":"1978","journal-title":"Postgrad Med J"},{"key":"2026011721304240900_ejhf1461-bib-0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/heart.87.2.126","article-title":"Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey","volume":"87","author":"Miura","year":"2002","journal-title":"Heart"},{"key":"2026011721304240900_ejhf1461-bib-0006","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5830\/CVJA-2012-046","article-title":"Cardiomyopathies and myocardial disorders in Africa: present status and the way forward","volume":"23","author":"Falase","year":"2012","journal-title":"Cardiovasc J Afr"},{"key":"2026011721304240900_ejhf1461-bib-0007","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0008","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2012.07.072","article-title":"Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy","volume":"61","author":"Kubanek","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0009","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ejhf.1216","article-title":"Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy","volume":"20","author":"Halliday","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0010","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jacc.2011.05.033","article-title":"Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study","volume":"58","author":"McNamara","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0011","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijcard.2010.01.011","article-title":"Heart failure etiology impacts survival of patients with heart failure","volume":"149","author":"Pecini","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0012","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Yusuf","year":"1991","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0013","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1388-9842(00)00130-6","article-title":"Baseline demographics of the Valsartan Heart Failure Trial. Val-HeFT Investigators","volume":"2","author":"Cohn","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0014","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"2026011721304240900_ejhf1461-bib-0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0016","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ejhf.496","article-title":"Use of evidence-based therapy and survival in heart failure in Sweden 2003\u20132012","volume":"18","author":"Thorvaldsen","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0017","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jchf.2015.06.012","article-title":"Characteristics, treatments, and outcomes of hospitalized heart failure patients stratified by etiologies of cardiomyopathy","volume":"3","author":"Shore","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0018","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0019","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/icvts\/ivx201","article-title":"Outcome of heart transplantation after bridge-to-transplant strategy using various mechanical circulatory support devices","volume":"25","author":"Yoshioka","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2026011721304240900_ejhf1461-bib-0020","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.healun.2016.08.018","article-title":"The registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Heart Transplantation Report-2016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Rossano","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2026011721304240900_ejhf1461-bib-0021","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.healun.2016.09.001","article-title":"The registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Yusen","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2026011721304240900_ejhf1461-bib-0022","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.healun.2016.08.017","article-title":"The registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Lund","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2026011721304240900_ejhf1461-bib-0023","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0024","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(09)62023-7","article-title":"Dilated cardiomyopathy","volume":"375","author":"Jefferies","year":"2010","journal-title":"Lancet"},{"key":"2026011721304240900_ejhf1461-bib-0025","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","article-title":"The diagnosis and evaluation of dilated cardiomyopathy","volume":"67","author":"Japp","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0026","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0027","doi-asserted-by":"crossref","first-page":"270ra6","DOI":"10.1126\/scitranslmed.3010134","article-title":"Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease","volume":"7","author":"Roberts","year":"2015","journal-title":"Sci Transl Med"},{"key":"2026011721304240900_ejhf1461-bib-0028","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: results of a large multicentre cohort study","volume":"7","author":"van Rijsingen","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"2026011721304240900_ejhf1461-bib-0029","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","article-title":"Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy","volume":"14","author":"van der Zwaag","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0030","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0031","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10741-009-9156-8","article-title":"Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics","volume":"15","author":"Fayssoil","year":"2010","journal-title":"Heart Fail Rev"},{"key":"2026011721304240900_ejhf1461-bib-0032","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamacardio.2016.4801","article-title":"Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial","volume":"2","author":"Silva","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0033","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","article-title":"Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy","volume":"45","author":"Duboc","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0034","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Raman","year":"2015","journal-title":"Lancet Neurol"},{"key":"2026011721304240900_ejhf1461-bib-0035","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0036","doi-asserted-by":"crossref","first-page":"8234","DOI":"10.4049\/jimmunol.177.11.8234","article-title":"Mimicry and antibody-mediated cell signaling in autoimmune myocarditis","volume":"177","author":"Li","year":"2006","journal-title":"J Immunol"},{"key":"2026011721304240900_ejhf1461-bib-0037","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/01.CIR.81.3.959","article-title":"Antibodies to ADP-ATP carrier \u2013 an autoantigen in myocarditis and dilated cardiomyopathy \u2013 impair cardiac function","volume":"81","author":"Schulze","year":"1990","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0038","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/ejhf.148","article-title":"Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcome","volume":"16","author":"Escher","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0039","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12024-014-9570-7","article-title":"The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts","volume":"10","author":"Nielsen","year":"2014","journal-title":"Forensic Sci Med Pathol"},{"key":"2026011721304240900_ejhf1461-bib-0040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1253\/circj.67.881","article-title":"Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure caused by viral myocarditis","volume":"67","author":"Kitaura-Inenaga","year":"2003","journal-title":"Circ J"},{"key":"2026011721304240900_ejhf1461-bib-0041","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0167-5273(01)00497-1","article-title":"The epidemiological features of heart failure in developing countries: a review of the literature","volume":"80","author":"Mendez","year":"2001","journal-title":"Int J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000176822","article-title":"The challenge of chagasic cardiomyopathy. The pathologic roles of autonomic abnormalities, autoimmune mechanisms and microvascular changes, and therapeutic implications","volume":"86","author":"Rossi","year":"1995","journal-title":"Cardiology"},{"key":"2026011721304240900_ejhf1461-bib-0043","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","article-title":"Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease","volume":"38","author":"Caforio","year":"2017","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0044","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.106.641472","article-title":"Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives","volume":"115","author":"Caforio","year":"2007","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0045","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(94)92339-6","article-title":"Evidence from family studies for autoimmunity in dilated cardiomyopathy","volume":"344","author":"Caforio","year":"1994","journal-title":"Lancet"},{"key":"2026011721304240900_ejhf1461-bib-0046","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy","volume":"12","author":"Sliwa","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0047","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/ejhf.586","article-title":"Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy","volume":"18","author":"Bauersachs","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0048","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner","year":"2007","journal-title":"Cell"},{"key":"2026011721304240900_ejhf1461-bib-0049","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ejheart.2008.07.005","article-title":"Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy","volume":"10","author":"Forster","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0002-9149(94)90906-7","article-title":"Incidence of myocarditis in peripartum cardiomyopathy","volume":"74","author":"Rizeq","year":"1994","journal-title":"Am J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0051","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ahj.2004.09.008","article-title":"Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy","volume":"150","author":"Warraich","year":"2005","journal-title":"Am Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0052","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11040","article-title":"Cardiac angiogenic imbalance leads to peripartum cardiomyopathy","volume":"485","author":"Patten","year":"2012","journal-title":"Nature"},{"key":"2026011721304240900_ejhf1461-bib-0053","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0054","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1200\/JCO.2005.13.300","article-title":"Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment","volume":"23","author":"Ewer","year":"2005","journal-title":"J Clin Oncol"},{"key":"2026011721304240900_ejhf1461-bib-0055","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.amjmed.2010.11.031","article-title":"Chemical cardiomyopathies: the negative effects of medications and nonprescribed drugs on the heart","volume":"124","author":"Figueredo","year":"2011","journal-title":"Am J Med"},{"key":"2026011721304240900_ejhf1461-bib-0056","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/euhj.1999.1761","article-title":"Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy","volume":"21","author":"Fauchier","year":"2000","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0057","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ejhf.1165","article-title":"Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge","volume":"20","author":"Ameri","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0058","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0059","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/ejhf.1292","article-title":"Activity and outcomes of a cardio-oncology service in the United Kingdom \u2013 a five-year experience","volume":"20","author":"Pareek","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0060","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.1991.03470120074036","article-title":"Cardiac toxicity 4 to 20 years after completing anthracycline therapy","volume":"266","author":"Steinherz","year":"1991","journal-title":"JAMA"},{"key":"2026011721304240900_ejhf1461-bib-0061","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jchf.2015.04.011","article-title":"\u2018Targeting the Heart\u2019 in heart failure: myocardial recovery in heart failure with reduced ejection fraction","volume":"3","author":"Wilcox","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0062","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa043046","article-title":"Neurohumoral features of myocardial stunning due to sudden emotional stress","volume":"352","author":"Wittstein","year":"2005","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0063","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrcardio.2014.37","article-title":"Pathophysiology and epidemiology of peripartum cardiomyopathy","volume":"11","author":"Hilfiker-Kleiner","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0064","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9149(81)90534-8","article-title":"The natural history of idiopathic dilated cardiomyopathy","volume":"47","author":"Fuster","year":"1981","journal-title":"Am J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0065","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1253\/circj.70.376","article-title":"Long-term prognosis of dilated cardiomyopathy revisited: an improvement in survival over the past 20 years","volume":"70","author":"Matsumura","year":"2006","journal-title":"Circ J"},{"key":"2026011721304240900_ejhf1461-bib-0066","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","author":"Halliday","year":"2019","journal-title":"Lancet"},{"key":"2026011721304240900_ejhf1461-bib-0067","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2011.10.001","article-title":"Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF","volume":"163","author":"Wilcox","year":"2012","journal-title":"Am Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0068","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jacc.2010.11.030","article-title":"Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment","volume":"57","author":"Merlo","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0069","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/eurjhf\/hfs026","article-title":"Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis","volume":"14","author":"Martinez-Selles","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0070","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"key":"2026011721304240900_ejhf1461-bib-0071","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/hrt.2011.225789","article-title":"Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy","volume":"97","author":"Rossi","year":"2011","journal-title":"Heart"},{"key":"2026011721304240900_ejhf1461-bib-0072","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jchf.2017.06.015","article-title":"Evolution of functional mitral regurgitation and prognosis in medically managed heart failure patients with reduced ejection fraction","volume":"5","author":"Nasser","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0073","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0074","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"Digitalis Investigation Group","year":"1997","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0076","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0140-6736(93)92930-R","article-title":"Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group","volume":"342","author":"Waagstein","year":"1993","journal-title":"Lancet"},{"key":"2026011721304240900_ejhf1461-bib-0077","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.90.4.1765","article-title":"A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees","volume":"90","year":"1994","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0078","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0079","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"2026011721304240900_ejhf1461-bib-0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"2026011721304240900_ejhf1461-bib-0081","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0082","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0083","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0084","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0085","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0086","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure","volume":"333","author":"Singh","year":"1995","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0087","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/CIRCULATIONAHA.117.028829","article-title":"Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure","volume":"136","author":"Elming Marie","year":"2017","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0088","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jchf.2016.02.019","article-title":"Lessons learned and insights gained in the design, analysis, and outcomes of the COMPANION trial","volume":"4","author":"Bristow","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0089","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.110.960898","article-title":"Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT)","volume":"123","author":"Zareba","year":"2011","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0090","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0091","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/ejcts\/ezs078","article-title":"Long-term results of mitral repair for functional mitral regurgitation in idiopathic dilated cardiomyopathy","volume":"42","author":"De Bonis","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026011721304240900_ejhf1461-bib-0092","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0093","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0094","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0095","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.CIR.0000048147.15962.31","article-title":"Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders","volume":"107","author":"Frustaci","year":"2003","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0096","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","article-title":"Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study","volume":"30","author":"Frustaci","year":"2009","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0097","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00392-016-1011-z","article-title":"Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy","volume":"105","author":"Escher","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0098","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.amjcard.2008.07.041","article-title":"Usefulness of immunosuppression for giant cell myocarditis","volume":"102","author":"Cooper","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0099","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00392-016-0986-9","article-title":"Betaferon in Chronic Viral Cardiomyopathy (BICC) trial: effects of interferon-beta treatment in patients with chronic viral cardiomyopathy","volume":"105","author":"Schultheiss","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0100","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(00)00568-4","article-title":"Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study","volume":"35","author":"Felix","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0101","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jjcc.2016.07.014","article-title":"Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: results from the observational prospective Bad Berka registry","volume":"69","author":"Ohlow","year":"2017","journal-title":"J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0102","doi-asserted-by":"crossref","first-page":"E133","DOI":"10.3390\/biom8040133","article-title":"Add-on immunoadsorption shortly-after optimal medical treatment further significantly and persistently improves cardiac function and symptoms in recent-onset heart failure \u2013 a single center experience","volume":"8","author":"Weinmann","year":"2018","journal-title":"Biomolecules"},{"key":"2026011721304240900_ejhf1461-bib-0103","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ejhf.1172","article-title":"Anthracycline-induced cardiomyopathy: secrets and lies","volume":"20","author":"Farmakis","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0104","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study","volume":"38","author":"Hilfiker-Kleiner","year":"2017","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0105","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2017.06.014","article-title":"Alcoholic cardiomyopathy: what is known and what is not known","volume":"43","author":"Mirijello","year":"2017","journal-title":"Eur J Intern Med"},{"key":"2026011721304240900_ejhf1461-bib-0107","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"2026011721304240900_ejhf1461-bib-0108","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/CIRCRESAHA.116.310370","article-title":"Postnatal cardiac gene editing using CRISPR\/Cas9 with AAV9-mediated delivery of short guide RNAs results in mosaic gene disruption","volume":"121","author":"Johansen","year":"2017","journal-title":"Circ Res"},{"key":"2026011721304240900_ejhf1461-bib-0109","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0111","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12265-009-9137-2","article-title":"The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice","volume":"2","author":"Olivotto","year":"2009","journal-title":"J Cardiovasc Transl Res"},{"key":"2026011721304240900_ejhf1461-bib-0112","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2003.05.009","article-title":"Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults","volume":"116","author":"Zou","year":"2004","journal-title":"Am J Med"},{"key":"2026011721304240900_ejhf1461-bib-0114","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9149(87)80107-8","article-title":"Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening","volume":"59","author":"Hada","year":"1987","journal-title":"Am J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1056\/NEJM199808063390602","article-title":"Screening for hypertrophic cardiomyopathy in young athletes","volume":"339","author":"Corrado","year":"1998","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0116","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0002-9149(03)00132-2","article-title":"Screening for hypertrophic cardiomyopathy in a young male military population","volume":"91","author":"Nistri","year":"2003","journal-title":"Am J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0117","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejmg.2010.07.007","article-title":"Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy","volume":"53","author":"Millat","year":"2010","journal-title":"Eur J Med Genet"},{"key":"2026011721304240900_ejhf1461-bib-0118","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0119","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/eurheartj\/ehx819","article-title":"The cardiomyopathy registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies","volume":"39","author":"Charron","year":"2018","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jchf.2017.09.011","article-title":"Clinical spectrum and management of heart failure in hypertrophic cardiomyopathy","volume":"6","author":"Maron","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0121","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0122","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2017.11.060","article-title":"De novo mitral regurgitation as a cause of heart failure exacerbation in patients with hypertrophic cardiomyopathy","volume":"252","author":"Kuperstein","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0123","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/eurheartj\/ehq136","article-title":"Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy","volume":"31","author":"Melacini","year":"2010","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0124","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","article-title":"Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging","volume":"5","author":"Olivotto","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0125","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/hrt.2003.031161","article-title":"Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy","volume":"91","author":"Thaman","year":"2005","journal-title":"Heart"},{"key":"2026011721304240900_ejhf1461-bib-0126","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0127","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0025-6196(11)60890-2","article-title":"Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy","volume":"83","author":"Olivotto","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"2026011721304240900_ejhf1461-bib-0128","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"2026011721304240900_ejhf1461-bib-0129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12265-009-9131-8","article-title":"Mechanical and energetic consequences of HCM-causing mutations","volume":"2","author":"Ferrantini","year":"2009","journal-title":"J Cardiovasc Transl Res"},{"key":"2026011721304240900_ejhf1461-bib-0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10741-005-5253-5","article-title":"Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes","volume":"10","author":"Tardiff","year":"2005","journal-title":"Heart Fail Rev"},{"key":"2026011721304240900_ejhf1461-bib-0131","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ncpcardio0859","article-title":"\u2018End-stage\u2019 hypertrophic cardiomyopathy: from mystery to model","volume":"4","author":"Yacoub","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2026011721304240900_ejhf1461-bib-0132","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jacc.2008.11.069","article-title":"The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy","volume":"54","author":"Maron","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0133","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jacc.2009.04.072","article-title":"The case for myocardial ischemia in hypertrophic cardiomyopathy","volume":"54","author":"Maron","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0134","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s12265-009-9124-7","article-title":"Hypertrophic cardiomyopathy: preclinical and early phenotype","volume":"2","author":"Ho","year":"2009","journal-title":"J Cardiovasc Transl Res"},{"key":"2026011721304240900_ejhf1461-bib-0135","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcmg.2011.11.021","article-title":"Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy","volume":"5","author":"Green","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026011721304240900_ejhf1461-bib-0136","doi-asserted-by":"crossref","first-page":"e003090","DOI":"10.1161\/CIRCHEARTFAILURE.116.003090","article-title":"Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy: a clinical-pathological study of 30 explanted hearts","volume":"9","author":"Galati","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0137","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2009.11.062","article-title":"Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations","volume":"55","author":"Girolami","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0138","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/eurjhf\/hfr110","article-title":"Genetic basis of end-stage hypertrophic cardiomyopathy","volume":"13","author":"Garcia-Pavia","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0139","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0002-9149(99)00282-9","article-title":"Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function","volume":"84","author":"Briguori","year":"1999","journal-title":"Am J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0140","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","article-title":"Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"118","author":"Maron","year":"2008","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0141","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2006.05.013","article-title":"Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy)","volume":"98","author":"Nistri","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0142","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0735-1097(03)00854-4","article-title":"Myocardial bridging in adult patients with hypertrophic cardiomyopathy","volume":"42","author":"Sorajja","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0143","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.RES.82.1.57","article-title":"Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy","volume":"82","author":"Schafers","year":"1998","journal-title":"Circ Res"},{"key":"2026011721304240900_ejhf1461-bib-0144","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2016.01.071","article-title":"The mitral valve in obstructive hypertrophic cardiomyopathy: a test in context","volume":"67","author":"Sherrid","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0145","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/eurheartj\/ehp588","article-title":"Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity","volume":"31","author":"Wu","year":"2010","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0146","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s12551-018-0432-5","article-title":"Anderson-Fabry disease in heart failure","volume":"10","author":"Akhtar","year":"2018","journal-title":"Biophys Rev"},{"key":"2026011721304240900_ejhf1461-bib-0147","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1093\/eurheartj\/ehm454","article-title":"A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium","volume":"28","author":"Weidemann","year":"2007","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0148","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacc.2011.03.020","article-title":"Exercise-induced left ventricular outflow tract obstruction in symptomatic patients with Anderson-Fabry disease","volume":"58","author":"Calcagnino","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0149","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2011.06.021","article-title":"Cystatin C and NT-proBNP as prognostic biomarkers in Fabry disease","volume":"104","author":"Torralba-Cabeza","year":"2011","journal-title":"Mol Genet Metab"},{"key":"2026011721304240900_ejhf1461-bib-0150","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.2009.371","article-title":"Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy","volume":"301","author":"Maron","year":"2009","journal-title":"JAMA"},{"key":"2026011721304240900_ejhf1461-bib-0151","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2010.03.020","article-title":"Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"106","author":"Olivotto","year":"2010","journal-title":"Am J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0152","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0153","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2016.01.023","article-title":"Contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy","volume":"67","author":"Maron","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0154","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1253\/circj.CJ-12-1561","article-title":"Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction","volume":"77","author":"Efthimiadis","year":"2013","journal-title":"Circ J"},{"key":"2026011721304240900_ejhf1461-bib-0155","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.amjcard.2009.07.057","article-title":"Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy","volume":"104","author":"Biagini","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0156","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/CIRCHEARTFAILURE.114.001843","article-title":"Clinical spectrum, therapeutic options, and outcome of advanced heart failure in hypertrophic cardiomyopathy","volume":"8","author":"Pasqualucci","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0157","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCHEARTFAILURE.114.001435","article-title":"Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant","volume":"7","author":"Rowin","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0158","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0159","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2459\/JCM.0000000000000361","article-title":"Clinical and genetic characterization of patients with hypertrophic cardiomyopathy and right atrial enlargement","volume":"18","author":"Limongelli","year":"2017","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2026011721304240900_ejhf1461-bib-0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-7120-8-7","article-title":". Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment","volume":"8","author":"Losi","year":"2010","journal-title":"Cardiovasc Ultrasound"},{"key":"2026011721304240900_ejhf1461-bib-0161","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0162","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/heartjnl-2014-306782","article-title":"Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry disease","volume":"101","author":"Patel","year":"2015","journal-title":"Heart"},{"key":"2026011721304240900_ejhf1461-bib-0163","doi-asserted-by":"crossref","first-page":"e002839","DOI":"10.1161\/JAHA.115.002839","article-title":"High-sensitivity troponin: a clinical blood biomarker for staging cardiomyopathy in Fabry disease","volume":"5","author":"Seydelmann","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026011721304240900_ejhf1461-bib-0164","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/heartjnl-2016-310138","article-title":"Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy","volume":"103","author":"Rosmini","year":"2017","journal-title":"Heart"},{"key":"2026011721304240900_ejhf1461-bib-0165","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/hrt.2004.035584","article-title":"The natural history of left ventricular systolic function in Anderson-Fabry disease","volume":"91","author":"Shah","year":"2005","journal-title":"Heart"},{"key":"2026011721304240900_ejhf1461-bib-0166","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0167","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0168","doi-asserted-by":"crossref","first-page":"353","DOI":"10.21037\/acs.2017.07.07","article-title":"Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience","volume":"6","author":"Rastegar","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"2026011721304240900_ejhf1461-bib-0169","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00392-007-0616-7","article-title":"Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience","volume":"97","author":"Kuhn","year":"2008","journal-title":"Clin Res Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCULATIONAHA.112.000849","article-title":"Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction","volume":"128","author":"Desai","year":"2013","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0171","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00392-007-0578-9","article-title":"One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response","volume":"96","author":"Faber","year":"2007","journal-title":"Clin Res Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0172","first-page":"CD008523","article-title":"Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy","author":"Qintar","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026011721304240900_ejhf1461-bib-0173","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0174","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ejheart.2008.03.006","article-title":"Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end-stage hypertrophic cardiomyopathy","volume":"10","author":"Rogers","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0175","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCHEARTFAILURE.110.959288","article-title":"Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy","volume":"4","author":"Topilsky","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0176","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/S0140-6736(09)61493-8","article-title":"Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data","volume":"374","author":"Mehta","year":"2009","journal-title":"Lancet"},{"key":"2026011721304240900_ejhf1461-bib-0177","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann Intern Med"},{"key":"2026011721304240900_ejhf1461-bib-0178","doi-asserted-by":"crossref","first-page":"e0173358","DOI":"10.1371\/journal.pone.0173358","article-title":"Enzyme replacement therapy for Anderson-Fabry disease: a complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies","volume":"12","author":"El Dib","year":"2017","journal-title":"PLoS One"},{"key":"2026011721304240900_ejhf1461-bib-0179","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jmedgenet-2016-104178","article-title":"Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study","volume":"54","author":"Hughes","year":"2017","journal-title":"J Med Genet"},{"key":"2026011721304240900_ejhf1461-bib-0180","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/eurheartj\/ehy072","article-title":"Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy","volume":"39","author":"Muntze","year":"2018","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0181","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gim.2012.44","article-title":"The emerging phenotype of long-term survivors with infantile Pompe disease","volume":"14","author":"Prater","year":"2012","journal-title":"Genet Med"},{"key":"2026011721304240900_ejhf1461-bib-0182","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2018.07.091","article-title":"Cardiac outcome in classic infantile Pompe disease after 13years of treatment with recombinant human acid alpha-glucosidase","volume":"269","author":"van Capelle","year":"2018","journal-title":"Int J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0183","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/CIRCHEARTFAILURE.114.001105","article-title":"Danon disease: clinical features, evaluation, and management","volume":"7","author":"D'Souza","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0184","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2016.08.050","article-title":"Differentiation of constriction and restriction: complex cardiovascular hemodynamics","volume":"68","author":"Geske","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0185","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM199701233360407","article-title":"Restrictive cardiomyopathy","volume":"336","author":"Kushwaha","year":"1997","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0186","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jacc.2018.01.016","article-title":"Spectrum of restrictive and infiltrative cardiomyopathies: Part 1 of a 2-Part Series","volume":"71","author":"Pereira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0187","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","article-title":"Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment","volume":"16","author":"Murphy","year":"2010","journal-title":"J Card Fail"},{"key":"2026011721304240900_ejhf1461-bib-0188","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCRESAHA.117.310982","article-title":"Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Muchtar","year":"2017","journal-title":"Circ Res"},{"key":"2026011721304240900_ejhf1461-bib-0189","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/01.CIR.101.21.2490","article-title":"Clinical profile and outcome of idiopathic restrictive cardiomyopathy","volume":"101","author":"Ammash","year":"2000","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0190","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.jacc.2007.02.061","article-title":"Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype","volume":"49","author":"Kubo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0191","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1532-5415.1997.tb02968.x","article-title":"Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults","volume":"45","author":"Rich","year":"1997","journal-title":"J Am Geriatr Soc"},{"key":"2026011721304240900_ejhf1461-bib-0192","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9149(83)80072-1","article-title":"Cardiovascular disease in the very elderly. Analysis of 40 necropsy patients aged 90 years or over","volume":"51","author":"Waller","year":"1983","journal-title":"Am J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0193","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Castano","year":"2017","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0194","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonzalez-Lopez","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0195","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/HCO.0b013e32832a1d2e","article-title":"Restrictive cardiomyopathy","volume":"24","author":"Mogensen","year":"2009","journal-title":"Curr Opin Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0196","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis","volume":"135","author":"Maurer","year":"2017","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0197","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cardfail.2018.07.001","article-title":"Myocardial contraction fraction by M-mode echocardiography is superior to ejection fraction in predicting mortality in transthyretin amyloidosis","volume":"24","author":"Rubin","year":"2018","journal-title":"J Card Fail"},{"key":"2026011721304240900_ejhf1461-bib-0198","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/ejhf.899","article-title":"Inotropic myocardial reserve deficiency is the predominant feature of exercise haemodynamics in cardiac amyloidosis","volume":"19","author":"Clemmensen","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0199","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/01.CIR.102.8.876","article-title":"Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy","volume":"102","author":"Rivenes","year":"2000","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0200","first-page":"2874902","article-title":"Restrictive cardiomyopathies: the importance of noninvasive cardiac imaging modalities in diagnosis and treatment \u2013 a systematic review","volume":"2017","author":"Rammos","year":"2017","journal-title":"Radiol Res Pract"},{"key":"2026011721304240900_ejhf1461-bib-0201","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/01.RES.0000126569.75419.74","article-title":"Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress","volume":"94","author":"Brenner","year":"2004","journal-title":"Circ Res"},{"key":"2026011721304240900_ejhf1461-bib-0202","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0203","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","article-title":"Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only","volume":"100","author":"Skinner","year":"1996","journal-title":"Am J Med"},{"key":"2026011721304240900_ejhf1461-bib-0204","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"2026011721304240900_ejhf1461-bib-0205","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol"},{"key":"2026011721304240900_ejhf1461-bib-0206","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0207","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","article-title":"Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs","volume":"20","author":"Castano","year":"2015","journal-title":"Heart Fail Rev"},{"key":"2026011721304240900_ejhf1461-bib-0208","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0209","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0210","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0211","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00408-015-9805-8","article-title":"Cardiac sarcoidosis: is it more common in men?","volume":"194","author":"Martusewicz-Boros","year":"2016","journal-title":"Lung"},{"key":"2026011721304240900_ejhf1461-bib-0212","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0213","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.carpath.2013.06.005","article-title":"Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist device","volume":"23","author":"Segura","year":"2014","journal-title":"Cardiovasc Pathol"},{"key":"2026011721304240900_ejhf1461-bib-0214","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjcard.2013.11.015","article-title":"Morphologic features of cardiac sarcoidosis in native hearts of patients having cardiac transplantation","volume":"113","author":"Roberts","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCEP.110.959254","article-title":"Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults","volume":"4","author":"Kandolin","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026011721304240900_ejhf1461-bib-0216","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12401","article-title":"Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults","volume":"25","author":"Nery","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026011721304240900_ejhf1461-bib-0217","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/pace.12277","article-title":"Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia","volume":"37","author":"Nery","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026011721304240900_ejhf1461-bib-0218","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0219","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","article-title":"L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy","volume":"9","author":"Oudit","year":"2003","journal-title":"Nat Med"},{"key":"2026011721304240900_ejhf1461-bib-0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00877096","article-title":"Iron overload cardiomyopathies: new insights into an old disease","volume":"8","author":"Liu","year":"1994","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026011721304240900_ejhf1461-bib-0221","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1527-5299.2001.00259.x","article-title":"Heart failure in beta-thalassemia","volume":"7","author":"Kremastinos","year":"2001","journal-title":"Congest Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0222","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(89)90264-X","article-title":"Survival and causes of death in thalassaemia major","volume":"2","author":"Zurlo","year":"1989","journal-title":"Lancet"},{"key":"2026011721304240900_ejhf1461-bib-0223","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0002-9343(01)00879-8","article-title":"Heart failure in beta thalassemia: a 5-year follow-up study","volume":"111","author":"Kremastinos","year":"2001","journal-title":"Am J Med"},{"key":"2026011721304240900_ejhf1461-bib-0224","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ejheart.2006.11.004","article-title":"NT-proBNP levels and diastolic dysfunction in beta-thalassaemia major patients","volume":"9","author":"Kremastinos","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2026011721304240900_ejhf1461-bib-0225","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.euje.2004.01.003","article-title":"Biventricular diastolic behaviour in patients with hypertrophic and hereditary hemochromatosis cardiomyopathies","volume":"5","author":"Palka","year":"2004","journal-title":"Eur J Echocardiogr"},{"key":"2026011721304240900_ejhf1461-bib-0226","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.euje.2006.02.004","article-title":"Use of strain and tissue velocity imaging for early detection of regional myocardial dysfunction in patients with beta thalassemia","volume":"8","author":"Hamdy","year":"2007","journal-title":"Eur J Echocardiogr"},{"key":"2026011721304240900_ejhf1461-bib-0227","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0228","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/CIRCULATIONAHA.115.021178","article-title":"Tropical endomyocardial fibrosis: natural history, challenges, and perspectives","volume":"133","author":"Grimaldi","year":"2016","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0229","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa0708629","article-title":"A population study of endomyocardial fibrosis in a rural area of Mozambique","volume":"359","author":"Mocumbi","year":"2008","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0230","first-page":"129","article-title":"Electrocardiogram in endomyocardial fibrosis","volume":"11","author":"Tharakan","year":"2011","journal-title":"Indian Pacing Electrophysiol J"},{"key":"2026011721304240900_ejhf1461-bib-0231","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/hrt.34.4.403","article-title":"Survival after first presentation with endomyocardial fibrosis","volume":"34","author":"D'Arbela","year":"1972","journal-title":"Br Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0232","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1258\/004947507781524665","article-title":"Echocardiographic, chest X-ray and electrocardiogram findings in children presenting with heart failure to a Ugandan paediatric ward","volume":"37","author":"Ellis","year":"2007","journal-title":"Trop Doct"},{"key":"2026011721304240900_ejhf1461-bib-0233","first-page":"133","article-title":"Degranulated eosinophils, eosinophil granule basic proteins and humoral factors in Nigerians with endomyocardial fibrosis","volume":"16","author":"Urhoghide","year":"1987","journal-title":"Afr J Med Med Sci"},{"key":"2026011721304240900_ejhf1461-bib-0234","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2015.03.012","article-title":"Role of ventricular assist therapy for patients with heart failure and restrictive physiology: improving outcomes for a lethal disease","volume":"34","author":"Grupper","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"2026011721304240900_ejhf1461-bib-0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2026011721304240900_ejhf1461-bib-0236","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.jacc.2016.03.593","article-title":"Efficacy of chemotherapy for light-chain amyloidosis in patients presenting with symptomatic heart failure","volume":"67","author":"Sperry","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026011721304240900_ejhf1461-bib-0237","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0238","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/CIRCULATIONAHA.118.035831","article-title":"Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis","volume":"139","author":"Solomon","year":"2019","journal-title":"Circulation"},{"key":"2026011721304240900_ejhf1461-bib-0239","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026011721304240900_ejhf1461-bib-0240","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0002-8703(87)90039-1","article-title":"Reversible cardiac dysfunction in hemochromatosis","volume":"113","author":"Rivers","year":"1987","journal-title":"Am Heart J"},{"key":"2026011721304240900_ejhf1461-bib-0241","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"key":"2026011721304240900_ejhf1461-bib-0242","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMct1004810","article-title":"Iron-chelating therapy for transfusional iron overload","volume":"364","author":"Brittenham","year":"2011","journal-title":"N Engl J Med"},{"key":"2026011721304240900_ejhf1461-bib-0243","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/1744666X.2018.1425142","article-title":"Imatinib for the treatment of hypereosinophilic syndromes","volume":"14","author":"Helbig","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"2026011721304240900_ejhf1461-bib-0244","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/j.seminhematol.2012.01.001","article-title":"Treatment of hypereosinophilic syndromes \u2013 the first 100 years","volume":"49","author":"Butterfield","year":"2012","journal-title":"Semin Hematol"},{"key":"2026011721304240900_ejhf1461-bib-0245","first-page":"151","article-title":"Results, indications and contra-indications of surgery in restrictive endomyocardial fibrosis: comparative study on 31 operated and 30 non-operated patients","volume":"62","author":"Bertrand","year":"1985","journal-title":"East Afr Med J"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.1461","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ejhf.1461","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ejhf.1461","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/21\/5\/553\/66193152\/eurjhf_21_5_553.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/21\/5\/553\/66193152\/eurjhf_21_5_553.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:31:24Z","timestamp":1768703484000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/21\/5\/553\/8408072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":245,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,4,16]]},"published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.1461","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2019,4,16]]},"assertion":[{"value":"2019-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}